Polyethylene having faster crystallization rate and improved environmental stress cracking resistance
View Patent ↗Disclosed is a polyethylene composition having faster crystallization rate and improved environmental stress cracking resistance. The polyethylene composition comprises a multimodal polyethylene and a nucleating agent. The multimodal polyethylene comprises from 25 to 50 wt % of a low molecular weight ethylene homopolymer component, from 25 to 50 wt % of a medium molecular weight ethylene copolymer component and from 25 to 50 wt % of a high molecular weight ethylene copolymer component. The polyethylene composition has an environmental stress cracking resistance (ASTM D1693, Condition B in 100% Igepal) greater than or equal to 40 days and a crystallization half time less than or equal to 70% of the crystallization half time of the multimodal polyethylene without nucleating agent.
1. A multimodal polyethylene composition comprising:
(a) from 20 ppm to 5,0000 ppm a nucleating agent selected from the group consisting of zinc glycerolate, calcium glycerolate, calcium hexahydrophthalate, zinc hexahydrophthlate, and mixtures thereof;
(b) from 25 to 50 wt % of a first ethylene homopolymer component which has a density within the range of 0.965 g/cm 3 to 0.973 g/cm 3 ;
(c) from 25 to 50 wt % of a second ethylene copolymer component which has a density within the range of 0.950 g/cm 3 to 0.962 g/cm 3 ; and,
(d) from 25 to 50 wt % of a third ethylene copolymer component which has a density within the range of 0.905 g/cm 3 to 0.935 g/cm 3 ,
wherein the multimodal polyethylene composition has a density from of 0.942 g/cm 3 to 0.959 g/cm 3 , a MI 2 from 0.2 dg/min to 30 dg/min, a crystallization half time less than or equal to 12 minutes at 124° C., and has an environmental stress cracking resistance of greater than or equal to 40 days, measured according to ASTM D 1693 condition B, in 100% Igepal,
wherein the multimodal polyethylene composition has a crystallization half time less than or equal to 70% of the crystallization half time of the multimodal polyethylene without the nucleating agent, and
wherein the first ethylene homopolymer component has a melt index MI 2 within the range of 50 dg/min to 250 dg/min, the second ethylene copolymer component has a melt index MI 2 within the range of 10 dg/min to 30 dg/min, and the third ethylene copolymer component has a melt index MI 2 within the range of 0.001 dg/min to 0.3 dg/min.
2. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition has of a crystallization half time less than or equal to 60% of the crystallization halftime of the multimodal polyethylene.
3. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition has a crystallization half time less than or equal to 50% of the crystallization half time of the multimodal polyethylene.
4. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition has a crystallization half time less than or equal to 9 minutes at 124° C.
5. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition has a crystallization half time less than or equal to 6 minutes at 124° C.
6. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition comprises from 50 ppm to 1,000 ppm of the nucleating agent.
7. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition has a MI 2 from 0.5 dg/min to 15 dg/min.
8. The multimodal polyethylene composition of claim 1 , wherein the first ethylene homopolymer component has a melt index MI 2 within the range of 100 dg/min to 250 dg/min; and,
the third ethylene copolymer component has a melt index MI 2 within the range of 0.01 dg/min to 0.1 dg/min.
9. The multimodal polyethylene composition of claim 1 , wherein the multimodal polyethylene composition comprises from 100 to 500 ppm of the nucleating agent.
10. The multimodal polyethylene composition of claim 1 , wherein the nucleating agent is calcium hexahydrophthalate.